Do Fosamax-type drugs increase the risk of osteonecrosis of the jaw for patients receiving dental implants?
Wynn
Richard L
RL
Department of Oral Craniofacial Biological Sciences, Dental School, University of Maryland at Baltimore, USA.
D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D000075202:Contraindications; D003758:Dental Implantation, Endosseous; D015921:Dental Implants; D004164:Diphosphonates / Q000009:adverse effects*; D006801:Humans; D007571:Jaw Diseases / Q000139:chemically induced*; D010020:Osteonecrosis / Q000139:chemically induced*; D012306:Risk
D050071:Bone Density Conservation Agents; D015921:Dental Implants; D004164:Diphosphonates